nicotine has been researched along with 1-methyl-4-phenylpyridinium in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Ganapathy, V; Leibach, FH; Prasad, PD; Wu, X | 1 |
| Fei, YJ; Ganapathy, V; Kekuda, R; Leibach, FH; Prasad, PD; Wang, H; Wu, X | 1 |
| Giacomini, KM; Schaner, ME; Zhang, L | 1 |
| Inui, KI; Masuda, S; Okuda, M; Saito, H; Urakami, Y | 1 |
| Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X | 1 |
| Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
| Conway, SJ; Ganapathy, V; George, RL; Huang, W; Leibach, FH; Wang, H; Wu, X | 1 |
| Akazawa, M; Inui, K; Okuda, M; Saito, H; Urakami, Y | 1 |
| Bednarczyk, D; Ekins, S; Wikel, JH; Wright, SH | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Basham, JK; Carr, LA; Rowell, PP; York, BK | 1 |
| Daniels, AJ; Diliberto, EJ; Reinhard, JF; Viveros, OH | 1 |
| Clarke, PB; Reuben, M | 1 |
| Cavalletti, M; Corsini, GU; Fascetti, F; Fornai, F; Tedeschi, D; Vaglini, F | 1 |
| Chancy, CD; Ganapathy, V; Huang, W; Kekuda, R; Rajan, PD; Smith, SB | 1 |
| Di Monte, DA; Quik, M | 1 |
| Jeyarasasingam, G; Quik, M; Tompkins, L | 1 |
| Aomine, M; Inada, T; Kinemuchi, H; Obata, T | 1 |
| Dohi, T; Kitayama, S; Kozai, K; Kumagai, K; Lin, Z; Mitsuhata, C; Morioka, N; Morita, K; Uhl, GR | 1 |
| Bezard, E; Xie, YX; Zhao, BL | 1 |
| Choi, H; Jung, YJ; Oh, E | 1 |
1 review(s) available for nicotine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Regulation of dopamine and MPP+ transport by catecholamine transporters.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Carrier Proteins; Catecholamine Plasma Membrane Transport Proteins; Cocaine; Dopamine; Drug Design; Humans; Membrane Transport Proteins; Nicotine | 2004 |
21 other study(ies) available for nicotine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.
Topics: Amines; Amino Acid Sequence; Base Sequence; Biological Transport; Carrier Proteins; Chromosomes, Human, Pair 5; Cloning, Molecular; DNA, Complementary; Guanidines; Human Genome Project; Humans; Ions; Membrane Proteins; Membrane Transport Proteins; Molecular Sequence Data; Organic Cation Transport Proteins; Pyridines; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Solute Carrier Family 22 Member 5; Symporters; Tetraethylammonium | 1998 |
Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.
Topics: Amino Acid Sequence; Animals; Cloning, Molecular; DNA-Binding Proteins; HeLa Cells; Humans; Hydrogen-Ion Concentration; Molecular Sequence Data; Octamer Transcription Factor-3; Oocytes; Placenta; Protein Conformation; Rats; Transcription Factors; Xenopus laevis | 1998 |
Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Topics: Carrier Proteins; Corticosterone; HeLa Cells; Humans; Membrane Proteins; Midazolam; Organic Cation Transporter 1; Permeability; Recombinant Proteins; Structure-Activity Relationship; Tetraethylammonium Compounds; Transfection | 1998 |
Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
Topics: Animals; Base Sequence; Carrier Proteins; Cations; Cell Line; Cell Membrane; DNA Primers; Dogs; Kidney Tubules; Membrane Proteins; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Rats; Tetraethylammonium | 1998 |
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium | 1999 |
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carnitine; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Humans; Membrane Proteins; Membrane Transport Proteins; Molecular Sequence Data; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Proteins; Structure-Activity Relationship; Symporters; Tetraethylammonium; Tissue Distribution | 2000 |
cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney.
Topics: Alternative Splicing; Amino Acid Sequence; Base Sequence; Cations; Cell Line; Cloning, Molecular; DNA, Complementary; Genetic Variation; Humans; Kidney; Molecular Sequence Data; Organic Cation Transport Proteins; Organic Cation Transporter 2; Tetraethylammonium; Tissue Distribution; Transfection | 2002 |
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.
Topics: Computational Biology; HeLa Cells; Humans; Models, Molecular; Organic Cation Transporter 1; Pyridinium Compounds; Quinolinium Compounds; Structure-Activity Relationship; Transfection | 2003 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Depression, Chemical; Dopamine; Hydrazines; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nicotine; Pyridines; Synaptosomes; Tobacco Smoke Pollution | 1992 |
Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Calcium; Catecholamines; Cattle; Cell Compartmentation; Cells, Cultured; Desipramine; Digitonin; Drug Interactions; Nicotine; Pyridines; Pyridinium Compounds; Subcellular Fractions; Tetrabenazine; Tyrosine 3-Monooxygenase | 1987 |
Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Carrier Proteins; Cell Membrane; Dextroamphetamine; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Nicotine; Rats; Rats, Sprague-Dawley; Synaptosomes | 1995 |
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetaldehyde; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Ditiocarb; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nicotine; Piperazines; Selegiline; Serotonin | 1996 |
Expression of the extraneuronal monoamine transporter in RPE and neural retina.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Biogenic Monoamines; Blotting, Northern; Carrier Proteins; Cells, Cultured; Eye; Female; Gene Expression; Humans; Hydrogen-Ion Concentration; In Situ Hybridization; Kinetics; Methamphetamine; Mice; Mice, Inbred ICR; Nicotine; Organic Cation Transport Proteins; Pigment Epithelium of Eye; Procainamide; Retina; RNA, Messenger; Steroids; Tetraethylammonium; Time Factors | 2000 |
Nicotine administration reduces striatal MPP+ levels in mice.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Corpus Striatum; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Nicotine; Nicotinic Agonists; Time Factors | 2001 |
Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture.
Topics: 1-Methyl-4-phenylpyridinium; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cell Death; Dopamine; Female; Immunohistochemistry; Neurons; Neuroprotective Agents; Nicotine; Organ Culture Techniques; Parkinson Disease; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substantia Nigra; Tobacco Use Disorder; Tyrosine 3-Monooxygenase | 2002 |
Nicotine suppresses 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Corpus Striatum; Dose-Response Relationship, Drug; Hydroxyl Radical; Male; Nicotine; Rats; Rats, Wistar | 2002 |
Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Binding Sites; Blotting, Western; Brain; Calcium; Cell Line; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Electrons; Free Radicals; Green Fluorescent Proteins; Humans; Hydrogen Peroxide; Intracellular Membranes; Male; Membrane Potentials; Microscopy, Confocal; Mitochondria; Mitochondrial Swelling; Nicotine; Oxidopamine; Oxygen; Permeability; Plasmids; Rats; Rats, Sprague-Dawley; Spectrophotometry; Time Factors | 2005 |
Effects of particulate matter and nicotine for the MPP+-induced SH-SY5Y cells: Implication for Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Death; Cell Line, Tumor; Cell Survival; Humans; Neurons; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Particulate Matter | 2021 |